Pages that link to "Q54636039"

The following pages link to Adenovirus vector-mediated in vivo gene transfer into adult murine retina. (Q54636039):

Displaying 43 items.

• Clinical Trials in Retinal Dystrophies (Q26767086) (← links)
• Promising and delivering gene therapies for vision loss (Q27007079) (← links)
• Gene therapy of inherited retinal degenerations: prospects and challenges (Q27009261) (← links)
• What Is Next for Retinal Gene Therapy? (Q28082800) (← links)
• Identification of key residues determining isomerohydrolase activity of human RPE65 (Q28245764) (← links)
• An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse (Q28353985) (← links)
• Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration (Q28581577) (← links)
• Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. (Q30411312) (← links)
• Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179 (Q30626026) (← links)
• Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. (Q33397385) (← links)
• Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems (Q33821596) (← links)
• Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk (Q33947904) (← links)
• Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders (Q33985663) (← links)
• Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer (Q34000123) (← links)
• My career path for developing gene therapy for blinding diseases: the importance of mentors, collaborators, and opportunities (Q34063520) (← links)
• Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications (Q34215308) (← links)
• Efficient gene transfer to retinal pigment epithelium cells with long-term expression (Q34406695) (← links)
• Vector platforms for gene therapy of inherited retinopathies. (Q34561531) (← links)
• A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina (Q34684652) (← links)
• Clinical characteristics and current therapies for inherited retinal degenerations (Q35045067) (← links)
• Lentiviral mediated gene delivery to the anterior chamber of rodent eyes (Q35153670) (← links)
• Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors (Q35763533) (← links)
• A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells (Q35864616) (← links)
• Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells (Q36014895) (← links)
• Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients (Q36147481) (← links)
• Regulatable gene expression systems for gene therapy applications: progress and future challenges (Q36157542) (← links)
• Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus (Q36242842) (← links)
• Regulatable gene expression systems for gene therapy (Q36569912) (← links)
• Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector (Q36586077) (← links)
• Clathrin adaptor AP1B controls adenovirus infectivity of epithelial cells. (Q37256819) (← links)
• Microvascular modifications in diabetic retinopathy (Q37879581) (← links)
• Preclinical models to investigate retinal ischemia: advances and drawbacks (Q38010704) (← links)
• Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer (Q39551137) (← links)
• Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization (Q40870038) (← links)
• Non-replicating expression vectors: applications in vaccine development and gene therapy (Q41006477) (← links)
• Highly efficient retinal gene delivery with helper-dependent adenoviral vectors (Q41114841) (← links)
• Gene therapy for inherited retinal degeneration (Q41677858) (← links)
• Retinal transduction profiles by high-capacity viral vectors (Q42208596) (← links)
• Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress (Q42762084) (← links)
• beta-Galactosidase transgene expression in transplanted rabbit retinal pigment epithelial cells in vivo (Q42828777) (← links)
• Human Vascular Endothelial Growth Factor A Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration (Q58779270) (← links)
• Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse (Q60215437) (← links)
• Has retinal gene therapy come of age? From bench to bedside and back to bench (Q93016526) (← links)